trauma. Injuries to the shoulder and upper arm,Injuries to the elbow and forearm,Injuries to the wrist and handInjuries to the hip and thigh,Injuries to the knee and lower leg,Injuries to the knee and lower leg,Injuries to the ankle and foot,
Conditions
Interventions
Intervention 1: in control group ketamine injection 50 mg intra nasal. Intervention 2: in intervention group injection of ketamin intranasal 0.75mg/kg.
Treatment - Drugs
in control group ketamine injection 50 mg intra nasal
in intervention group injection of ketamin intranasal 0.75mg/kg
Sponsors
Deputy of Research- Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 85 Years
Inclusion criteria
Inclusion criteria: structural disease of upper airway, age<15 yr, low LOC, dementia, unstable situation, patient request of analgesic, neck pain, headache, chest pain, rise in ICP, history of rise of Iop, person who take analgesic in last 24 hour, pregnant women, BP over 180/110, acute cronary disease, heart failure, ketamine sensitivity, nasal fracture & bleeding, use of opioid & analgesic in EMS or triage, recent nasopharynx and facial surgery, orbit & eye trauma, head trauma.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 10,20,30,40,60 min after injection drug. Method of measurement: numeric rating scale protocol. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Sara Payami
Tehran University of Medical Sciences
Outcome results
None listed